Emulate Stock

Organs-on-Chips Company

Sign up today and learn more about Emulate Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Founders Fund


Boston MA, US

Total Funding


About Emulate Stock

Emulate develops Organs-on-Chips technologies through an automated human bioemulation platform that aims to mimic true human physiology so that responses to medicines, chemicals, and diseases can be accurately predicted. Through co-innovation with collaborators and internal programs, Emulate aims to advance product innovation, design, and safety across a range of applications in drug development, personalized medicine, agriculture, and chemical-based consumer products.

Emulate was founded in 2013 and is based in Bostom, MA. Notable investors in Emulate include Founders Fund, Glass Wall Syndicate, and Starlight Ventures.


Funding History

July 2014$12.0M
March 2016$45.0M
June 2018$36.0M
August 2019$28.2M
August 2021$20.7M
August 2021$60.4M


Chief Executive Officer

Jim Corbett

Chief Financial Officer

Scott Kantor


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: